BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 11156249)

  • 1. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
    Lee ES; Schafer JM; Yao K; England G; O'Regan RM; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2000 Dec; 6(12):4893-9. PubMed ID: 11156249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C; Gajdos C; Cheng D; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
    Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
    Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
    Schafer JM; Lee ES; O'Regan RM; Yao K; Jordan VC
    Clin Cancer Res; 2000 Nov; 6(11):4373-80. PubMed ID: 11106256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
    Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
    Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
    Gottardis MM; Jiang SY; Jeng MH; Jordan VC
    Cancer Res; 1989 Aug; 49(15):4090-3. PubMed ID: 2743303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts.
    Schafer JM; Lee ES; Dardes RC; Bentrem D; O'Regan RM; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2001 Aug; 7(8):2505-12. PubMed ID: 11489833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.
    Cook KL; Wärri A; Soto-Pantoja DR; Clarke PA; Cruz MI; Zwart A; Clarke R
    Clin Cancer Res; 2014 Jun; 20(12):3222-32. PubMed ID: 24928945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of estrogen receptor and epidermal growth factor receptor by tamoxifen under high and low estrogen environments in MCF-7 cells grown in athymic mice.
    Koibuchi Y; Iino Y; Uchida T; Andoh T; Horii Y; Nagasawa M; Horiguchi J; Maemura M; Takei H; Yokoe T; Morishita Y
    Oncol Rep; 2000; 7(1):135-40. PubMed ID: 10601607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of drug resistance to tamoxifen in breast cancer.
    Schafer JM; Bentrem DJ; Takei H; Gajdos C; Badve S; Jordan VC
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):75-83. PubMed ID: 12650703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.
    Gottardis MM; Wagner RJ; Borden EC; Jordan VC
    Cancer Res; 1989 Sep; 49(17):4765-9. PubMed ID: 2758410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
    Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
    Wolf DM; Langan-Fahey SM; Parker CJ; McCague R; Jordan VC
    J Natl Cancer Inst; 1993 May; 85(10):806-12. PubMed ID: 8487325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.